Mass vaccination as a control measure
We then followed emergency planning principles to deliver an integrated response, working with Public Health Wales, our three coterminous local authorities and voluntary organisations and publishing weekly newsletters for health professionals. We estimated we had over 9,000 under-vaccinated children to protect through MMR vaccination.
Our local response resulted in delivering over 25,000 MMR vaccinations to all ages through: a. GP vaccinations b. High school and college vaccinations c. Drop-in sessions in out-patient clinics d. Open access occupational health vaccinations for health staff e. Vaccine provision to local prisons for prisoners and staff f. Health visitors contacting parents of under-vaccinated children on their case loads and encouraging vaccination. g. Midwives advising pregnant mums of the risks to themselves and their unborn babies and encouraging vaccination of under-vaccinated children in their households. h. Vaccination of under-vaccinated care staff, clients and patients born from 1970 onwards in long-stay residential and nursing home facilities, psychiatric and learning disability units. i. Working with local universities to promote MMR for students through their GPs or drop-in sessions.
We communicated with the public through social media. The public used Health Board internet sites to discuss concerns and give support to each other.
Learning Areas:Protection of the public in relation to communicable diseases including prevention or control
Describe the measures taken and the outcomes of a community mass MMR vaccination programme delivered during a measles outbreak. Describe the ways in which local services have been strengthened for incidents in the future where mass vaccination may be required.
Qualified on the content I am responsible for because: I am a specialist doctor in Public Health on the UK consultant register and hold a position as Consultant in Communicable Disease Control in Public Health Wales
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.